by McKesson Ventures | May 6, 2020 | Portfolio News
GRAIL announced that it has completed a $390 million Series D financing round. New investors including Public Sector Pension Investment Board (PSP Investments), Canada Pension Plan Investment Board (CPP Investments), and two undisclosed investors joined existing...
by McKesson Ventures | May 6, 2020 | Portfolio News
Experts say the U.S. will need about 300,000 human tracers to chart and break ongoing expansion of the coronavirus pandemic, but we currently only have between 8,000 and 14,000. In a recent Rock Health post, the firm recommends combining a surge in human tracers,...
by McKesson Ventures | May 6, 2020 | Portfolio News
Novartis has announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of its Enerzair® Breezehaler® as a maintenance treatment of asthma in adult patients not...
by McKesson Ventures | May 6, 2020 | Portfolio News
One benefit of the coronavirus pandemic is the increasing usage of telehealth. The virus has forced an end to many non-urgent medical visits, and doctors are connecting with COVID and non-COVID patients virtually. According to Dr. Roy Schoenberg, CEO of telehealth...
by McKesson Ventures | May 6, 2020 | Portfolio News
The COVID-19 crisis has brought telehealth to the forefront as a way to screen for the disease and to manage care for high-risk patients with chronic illnesses. In fact, among U.S. adults, two-thirds said COVID-19 has made them more willing to try telehealth options....
